Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01550783 · ClinicalTrials.gov registry record · NA
Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 1,335
- Enrollment target
NCT01550783 is a NA study that has completed, run by University of Washington. The registered enrollment target is 1,335 participants.
The verdict
NCT01550783, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,335 participants
- Enrollment target
Study Summary
This randomized clinical trial studies home-based HPV or clinic-based Pap screening for cervical cancer. It is not yet known whether home-based screening is more effective, cost-effective, and/or acceptable than clinic-based screening for cervical cancer.
Interventions
- OTHER Questionnaire Administration
- OTHER Cytology Specimen Collection Procedure
- OTHER Cervical Papanicolaou Test
- PROCEDURE Screening Method
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,335 participants |
| Start Date | 2012-03 |
| Est. Completion | 2017-11-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01550783
The ClinicalTrials.gov registry entry for NCT01550783 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,335 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Questionnaire Administration is the first listed.
NCT01550783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01550783 about?
NCT01550783 is a clinical study titled "Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening". This randomized clinical trial studies home-based HPV or clinic-based Pap screening for cervical cancer. It is not yet known whether home-based screening is more effective, cost-effective, and/or acceptable than clinic-based screening for cervical cancer.
What is the current status of trial NCT01550783?
This trial is currently completed. It is a NA study. The enrollment target is 1,335 participants. The study started on 2012-03. Estimated completion is 2017-11-16.
What interventions are being tested in trial NCT01550783?
The interventions under investigation include: Questionnaire Administration (OTHER), Cytology Specimen Collection Procedure (OTHER), Cervical Papanicolaou Test (OTHER), Screening Method (PROCEDURE).
Who is sponsoring clinical trial NCT01550783?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.